Literature DB >> 3159188

Membrane complement receptors specific for bound fragments of C3.

G D Ross, M E Medof.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3159188     DOI: 10.1016/s0065-2776(08)60341-7

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  90 in total

1.  Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.

Authors:  W S Hlavacek; C Wofsy; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Strong associations between RFLP and protein polymorphisms for CD46.

Authors:  A N Wilton; R W Johnstone; I F McKenzie; D F Purcell
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Deposition and degradation of C3 on type III group B streptococci.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).

Authors:  I Csípö; E Kiss; P Soltész; P Antal-Szalmás; G Szegedi; J H Cohen; R P Taylor; M Kávai
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

6.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

7.  The inhibition of CR1 mobilization of human granulocytes by the presence of erythrocytes. A possible mechanism for intravascular regulation of granulocyte modulation.

Authors:  J Forslid; G Halldén; J Hed
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

8.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

Authors:  R P Taylor; W M Sutherland; C J Reist; D J Webb; E L Wright; R H Labuguen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Histochemical contributions to the binding mechanism of complement (CR1, CR2) receptors.

Authors:  F Baranyay
Journal:  Pathol Oncol Res       Date:  2009-04-08       Impact factor: 3.201

10.  The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Authors:  M Tonoli; K A Davies; P J Norsworthy; J Cohen; M J Walport
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.